ClearScanAI

Company Industry:

HealthTech

Company Type:

No items found.

Cohort:

2025

Responsible coach:

Olof Berglund

Website:

clearscanai/ north_east

Currently at Sting

Yes

Propel Capital Investment

Yes

Identify women that should go for supplemental breast cancer screening.

ClearScanAI identifies women who are at risk of having missed breast cancer during screening mammography and that would benefit from supplemental screening techniques such as MRI. By using its AI system in a clinical trial at Karolinska Hospital, it has been proven to stratify women at risk 4x better than using breast density alone.

‍